>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

March 18, 2014

FDA MedWatch - Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine

Summary:

Merit Medical Systems Custom Procedural Trays Kits Recall Particulates Found in Hospira Lidocaine

March 18, 2014

McKesson Technologies Anesthesia Care: Recall - Patient Case Data May Not Match Patient Data

Summary:

McKesson Technologies Anesthesia Care Recall Patient Case Data May Not Match Patient Data

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Rebukes CMS Rule for Jeopardizing Patient Safety and Quality Health Care

Thursday, November 01, 2012

ASA today expressed its serious concern regarding the Centers for Medicare & Medicaid Services' (CMS) decision to adopt a new and untested national policy that will allow Medicare funds to be used to pay untrained providers to diagnose and treat chronic pain. The policy jeopardizes patient safety, lowers the quality of health care and increases the risk for fraud and prescription drug abuse.

"The basic premise of this rule is flawed," said ASA President John M. Zerwas, M.D. "At a time when government health care programs are spending millions of dollars pursuing comparative effectiveness, value-based payments and other quality related measures, it is baffling that CMS would pursue a policy departing so considerably from using evidence-based norms and the 'triple aim' of improving care, improving health and reducing cost." 

Read ASA's full response.

Read chronic pain excerpt of CMS rule.

Read full CMS rule.

« Back to Washington Alerts